Arch Grants


Home | Browse

What is Geneoscopy?

Geneoscopy is developing a method to non-invasively screen for colorectal cancer by evaluating the mRNA expression profiles of stool samples. Geneoscopy won first place at the Accelerate St. Louis Challenge in 2016, the Idea Bounce at Washington University Business School in 2015, the 2015 Pipeline Innovator of the Year from Washington University, the Wharton Venture award, and placed second at TechCrunch St. Louis 2015.

Company Leadership

Erica Barnell

Erica Barnell is the CEO of Geneoscopy and a 2016 Arch Grants Recipient.

Erica has both a B.S. in Biological Sciences and in Applied Economics and Management from Cornell University. Erica previously worked for six years as a Research Technician at Washington University School of Medicine to evaluate the malnutrition of children in Africa. Erica won first place in the 2013 Big Idea Competition at Cornell.

Andrew Barnell

Andrew Barnell is the CFO of Geneoscopy, a 2016 Arch Grants Recipient.

Andrew received a B.S. in Applied Economics and Management from Cornell and is completing an MBA in Healthcare Management & Entrepreneurial Management from the Wharton School. Andrew spent two years in J.P. Morgan’s healthcare investment banking group in New York working on a variety of transactions primarily in the biotech, medical devices, and life science tools sectors, as well as two years working at Lindsay Goldberg, a middle-market private equity firm focused on providing long-term growth capital for family owned businesses.

Yiming Kang

Yiming Kang is the CTO at Geneoscopy, a 2016 Arch Grants Recipient.

Yiming has a B.S. in Biomedical Engineering from the University of Utah and an M.Eng in Biomedical Engineering from Cornell University. Yiming is also pursuing a Ph.D. in Computer Science at Washington University in St. Louis.

Similar Startups

Other companies you might be interested in: